LSB Industries, Inc. (LXU) Earnings Call Transcript & Summary

November 10, 2020

New York Stock Exchange US Materials Chemicals conference_presentation 27 min

Earnings Call Speaker Segments

Vincent Andrews

analyst
#1

Hi. This is Andrew again and we're back with LSB Industries. And with us is Cheryl Maguire, Executive Vice President and CFO. Welcome, Cheryl, thank you for your time today.

Cheryl Maguire

executive
#2

Thank you for having us.

Vincent Andrews

analyst
#3

Before we get started, I have to remember to read the important disclosures which is effectively that we invite all of you to visit the Morgan Stanley website at morganstanley.com/researchdisclosures to read these important disclosures and to seek out your Morgan Stanley representative with any questions you may have. [Operator Instructions]

Vincent Andrews

analyst
#4

And with that, let's get started. And maybe, Cheryl, maybe the best thing to do just for folks that might be new to the LSB stories, maybe just give us a background on the business model in terms of your end market diversity as well as your contract types.

Cheryl Maguire

executive
#5

Sure. Well thanks again for having us, Vincent. So LSB Industries is a nitrogen chemical company and, yes, we're diversified across a few different end markets. We principally sell into fertilizer markets and then we have 50% of our business as well going into industrial and mining end markets. And so we certainly like the industrial side of the business, those tend to be more contractual, 2- to 3-year contracts, which are generally more of a cost-plus model. And so they -- those margins tend to hold up well. On the fertilizer side of the business, those contracts are -- those are primarily spot-type sales. And so certainly subject to some of the volatility we see today.

Vincent Andrews

analyst
#6

And what would you -- how would you characterize your overall mix of revenue in terms of spot versus cost-plus type contracts?

Cheryl Maguire

executive
#7

I would say, if you think about revenues, 50% of the business, like I said, is fertilizer, and that's going -- those are all spot contracts. On the industrial and mining side, I would say probably 50% of those contracts are more cost-plus contracts.

Vincent Andrews

analyst
#8

Maybe actually revenue is the wrong way to think about it. Should we think about it in terms of EBITDA? Or just profit in terms of the contract breakdown? Because presumably the spot business can move around and shift the revenue mix. So is that not -- should we think about it in terms of volume? Which way do you guys think about it internally?

Cheryl Maguire

executive
#9

Yes. I mean we generally think about it more on the revenue side of things. So I think that's probably fair.

Vincent Andrews

analyst
#10

Okay. And then maybe just help us understand the facilities you have. Where are they located? What sort of competitive advantages do they have about them versus others positioned in the market?

Cheryl Maguire

executive
#11

Sure. So We have 3 plants that we own and 1 that we operate. So the 3 that we own, we have 1 in El Dorado, Arkansas. So we see advantages there, trucks going West and Western U.S. via rail, so we can really reach those markets on the West side. With Pryor, we have a plant in Pryor, Oklahoma, and we generally sell into the Southern Plains and Northern Plains markets there. And then with Cherokee, Alabama, that plant has access via barge as well as rail and trucks, so some good logistical advantages. And we generally see a freight advantage of $8 to $10 over at UAN coming from the Gulf. So -- and then the fourth plant we operate for a large global chemical company in its management fee-type arrangement.

Vincent Andrews

analyst
#12

Okay. And maybe just to ask a question about that type of arrangement. I mean is that a business that you're looking to expand in? Sort of the operation of third-party plants? Or is this something that's just sort of part of your existing business and you'd rather be a wholly-owned operator?

Cheryl Maguire

executive
#13

Yes. It's part of our existing business and we have a really good relationship there and we like that contract. But I'd say no, I'd say we're more focused on owning plants.

Vincent Andrews

analyst
#14

Okay. Obviously, this has been a challenging year for everybody with the pandemic. How would you sort of discuss how your businesses have been impacted sort of as we sort of move through the first half of the year, which was probably the most severe impact and now the second half of the year is sort of the beginning of the recovery. And where are we versus sort of the 2019 baseline? And how much progress can you make against that before there's a vaccine versus after there's a vaccine?

Cheryl Maguire

executive
#15

Right. Well I would say the biggest volume impact that we've seen has been on the industrial side of the business. If you think about nitric acid, one of our key products, it's sold into polyurethane end markets which are really affected by automotive and housing, and so there was definitely a slowdown in those markets beginning in March. And we've seen recovery in the second and third quarters but certainly not back to pre-pandemic levels. On the mining side, we've seen some closures of mines that have since opened up and so we're seeing some pickup on the volume side. And so I think all in, year-to-date, we've probably had about $7 million to $8 million of EBITDA lost as a result of the volume impacts of the pandemic. The pricing side, it's a little bit harder to quantify when -- on pricing. There's certainly an impact because of the slowdown on industrial ammonia applications. So what we're seeing is just more supply of ammonia given the lack of demand on the industrial side. And that's certainly weighing on pricing. I mean we're -- we like to attract the Tampa ammonia benchmark price and it's tracking around $235 per metric ton, which is a pretty low price. And we think some of that buildup is -- or some of that impact is coming from lower industrial uses of ammonia. And that started to come back. The other thing, too, though, is back with the stay-at-home orders back in March and April, you've really seen demand for ethanol drop off. And of course, with corn, 40% of corn going into ethanol in the U.S., we've seen a direct correlation for lower corn futures, which is impacting pricing of fertilizers as well because most of our fertilizers are going on corn. So there was definitely an impact there. And I think the other thing I would say is back with the stay-at-home orders, we've really seen natural gas pricing come down, especially in Europe. And when that happens, I think what we've seen is just the low-cost advantage that we have here in the U.S. was pretty well wiped out when gas dropped in Europe down to comparable Henry Hub pricing. So what that did for us is just add, I think, more marginal production. And so with more supply of a product in the market, it certainly also is weighing on pricing. So there are several factors at play with the pandemic that have impacted us this year.

Vincent Andrews

analyst
#16

Now we've seen some of that reverse though now, right, because you've got -- corn crop has just revised smaller again about 1.5 hours ago; corn futures are over $40, which nobody anticipated, who thought it was going to happen in a COVID year but here we are; European gas prices have gone back up, now U.S. gas prices are moving up with it so there's a little bit of an offset there. But the operating environment certainly we got an early harvest, so should have a good fall application season. Phosphate producers are back running full-out whereas a year ago, they were taking curtailments in terms of producing industrial ammonia. So it would seem like things are starting to move despite the pandemic in a better overall direction than anybody would have guessed a year ago, not least of which 6 months ago. So how do you think that sets you up for the balance of this year and into next year?

Cheryl Maguire

executive
#17

Yes. I would agree with all of that. I mean there's definitely some good optimism heading into next year. And the other one that I would add in addition to what you said is farmer economics or grower economics. They -- the growers seem to be going into next year with good balance sheets. And that's certainly, we think, going to lend itself to some higher pricing next year, farmers with good balance sheets coupled with corn futures being up over $4 means we should see some higher fertilizer pricing heading into next year. Good demand, it seems, coming out of China. I mean, and as you mentioned, gas costs in Europe coming back up, I think, $4.50, $5, potentially, today. So rising faster than certainly what we're seeing here in the U.S., and I think that will help as well. So I agree. We see some good optimism and think that, that sets us up for next year. And then the other thing too is with the storms across Iowa, I think it took out, what, 10 million acres of corn, certainly leading to lower-ending inventory stock. So I think that will help, too. So good things at play and some good recovery, we hope, next year.

Vincent Andrews

analyst
#18

You mentioned UAN before and, obviously, one of the challenges that market's had in the last year or so is just that the change in the export capability into Europe. How have you been -- how has LSB been trying to manage that?

Cheryl Maguire

executive
#19

Yes. So I think what we've seen definitely is a lot less UAN leaving the U.S., which has certainly caused some downward pressure on pricing and I think there's certainly a drive to keep imports out, which is, again, keeping UAN pricing down. So we're a bit of a smaller player in the UAN market compared to some of the -- our larger peers that are out there. But we've been working on some different contracts, some different distribution, going into some different markets where there's not so much UAN. So we're trying to deal with it by reaching out to some different markets and going places that we haven't historically gone with UAN. And UAN continues to trade at a discount to urea. So we're hopeful that, that trend reverses next year back to more normal relationships.

Vincent Andrews

analyst
#20

And you said that your nitric acid business hadn't sort of come back and obviously the sales into polyurethane. I'm just wondering, is some of that because there have been -- with all the hurricanes we had, there were handful of polyurethanes outages. So has that been sort of an inhibitor to getting back? Because we sort of have a feeling that polyurethanes demand, just given everything that's going on in housing and in white goods and so forth, might be very strong to finish the year. So maybe you could just sort of characterize, is it just because your customers weren't operating? Or is it because you're not seeing the actual demand pull to the end market?

Cheryl Maguire

executive
#21

Yes. We're definitely seeing recovery in the -- we've seen good recovery in the third quarter compared to where we were coming off of the first quarter and into the second quarter. When we think about the impact to the business, I think we -- lost sales were probably $3.5 million in the second quarter versus $1.5 million in the third quarter. So we're definitely seeing pickup in nitric acid and seeing that again continue to improve in the fourth quarter. Some of it was impacted with hurricanes. But you're right. I mean the -- we're seeing significant demand coming out of the housing markets. The automotive industry was slow to come back. I think they were operating at 50% for a while, but they're coming back stronger now, too. And so that certainly is helpful for nitric acid demand to finish the year.

Vincent Andrews

analyst
#22

And you've talked for some time now about improving the reliability of your plants. What are the specific actions that you're taking? And how much room for improvement is there?

Cheryl Maguire

executive
#23

Yes. So we've -- some of the specific actions that we've taken, I mean, we've invested about $1 billion of capital into the plants over the last 7 years. And most recently, back in the fourth quarter of '19, we put in a new urea reactor at Pryor. We put in a new sulfuric acid converter at El Dorado. We've upgraded our maintenance management system and have been very focused on preventative maintenance as opposed to running until the plant -- if something breaks and then you fix it, that can be expensive. So really more preventative in nature. We've really tried to upgrade our talent to make sure that we have the right people across the organization. So there's a lot of different things that we've been doing. And we're on track for several production records here in 2020. I mean we'll have record ammonia production, record UAN production, record sulfuric acid production, DEF -- I mean HDAN. There's some really good things that are happening. But we do still have some room for improvement and some additional work to be done. If you think about baseball, we're probably in the eighth inning. So definitely more work to be done over the next several years.

Vincent Andrews

analyst
#24

So when you kind of put it all together, is there a way you like to kind of contextualize or frame a range of outcomes for the earnings power of the company headed into next year?

Cheryl Maguire

executive
#25

Yes. So We think about it 2 different ways. Certainly, pricing recovery is one way to think about it. I think we believe we're in a low-pricing environment today and there's lots of optimism going into next year with respect to pricing. And so we do have a grid out there in our earnings presentation which basically shows benchmark pricing for Tampa and benchmark gas cost. And so if you say, assume a $300 Tampa environment and a $3 gas environment, the earnings power from an EBITDA perspective is around $120 million of EBITDA. So that gives you, I guess, a reference point in terms of the earnings power with pricing and the recovery of the fertilizer markets. But the other thing we spend a lot of time thinking about is pricing isn't really a good strategy, hoping for pricing to come back is not really a good strategy. So we're focused on how can we get to $100 million of EBITDA even in the current low pricing environment that we have today. And so with that, there's several things that we've been working on over the last 12 months and that will continue into next year. That adds that incremental EBITDA. And so a couple of things just for reference. We've signed a new nitric acid agreement for El Dorado facility. It's a 7-year contract for 70,000 to 100,000 tons of nitric acid, and that basically allows us to sell out the nitric acid capacity at El Dorado, effectively upgrading ammonia. And as you know, the more you upgrade, the better margins that you get from the business. And so that's one thing that we've done. A couple of other things where we've signed a new contract for a gas plant for CO2 at El Dorado. We currently vent CO2, so by having a gas plant there, we're capturing CO2 and selling it like we do at El Dorado or at Cherokee and Pryor. So incremental EBITDA from NaSH. We've got some new storage that we've added that allows us to position product better going into season and selling it in a high-price environment versus off-season. And so there's several things we're working on, some cost rationalization, some of the other work that has to be done to get us through the ninth inning on the operations' side, some recovery of COVID volumes. So there's several other things, I think, that will help get us to that $100 million of EBITDA even in a low price. So pricing recovery would just be gravy on top of that.

Vincent Andrews

analyst
#26

Okay. And maybe bridging that to your capital structure, I mean, obviously, the more EBITDA goes up, the more that helps the capital structure. But what other nonearnings-related initiatives you have to try to improve the capital structure?

Cheryl Maguire

executive
#27

Yes. So we have an expensive capital structure. The biggest contributing factor to that was some cost overruns that we had at our El Dorado plant during the ammonia expansion work that was done back in 2013 to 2016. So we had to go out and get some additional financing to help pay for those cost overruns at the plant. We have a -- we are -- we've been pretty public about litigation that we've brought against the general contractor for that work that was done. We're seeking over $100 million in damages for gross negligence and fraud. And we think that, that case has serious merits. And so of course, any award from that lawsuit would be used for fixing or paying down some of that preferred equity that we have on the balance sheet. The other thing too is, in addition to free cash flow, we do -- we're working on the earnings power of the company. And we think what that does is it allows us to refinance the senior notes. We have -- they're callable today at 107% in May of 2021, that drops to 103.6%. And so we think that if we can generate $100 million of EBITDA, for example, that allows us to probably get a re-rating on our debt and that would drop the cost of interest down to 200 basis points, maybe below where we are today. And so it allows us to take on a bit more debt and then pay off a portion of that preferred, which is callable at par. So there are several things that we think are paths to improving the capital structure.

Vincent Andrews

analyst
#28

And on the litigation against the EPC Contractor, where does that sit within the legal process at present? How close to a formal or informal resolution are you?

Cheryl Maguire

executive
#29

So I think that's probably one of the biggest impacts we've had as a result of the pandemic is the delay of the trial. We had been prepared to go to trial early in 2020. And that's a jury trial. And as you can imagine, not really conducive to a pandemic-type environment. And so It's been delayed. The litigation now has probably been delayed to this first half of 2021 before we'll be able to prosecute. But at the end of the day, we are ready to go and we think we have some serious merit to that case.

Vincent Andrews

analyst
#30

But it doesn't sound like it's something that's going to be settled anytime soon. It's going to go through -- expect to go through the actual court process.

Cheryl Maguire

executive
#31

Yes. I mean I think there's several paths I think that, that could go. But yes, for right now, we're planning on a first half of 2021, at least, to go to trial.

Vincent Andrews

analyst
#32

Okay. And how does -- how do you think at a high level, big picture, strategically, you look at the broader agriculture, chemical, ag chem, whatever, however you want to sort of line up your peers, you're certainly on the smaller side of the spectrum of the companies. You've got 3 plants. If -- maybe M&A is not on the top of your list of things to do as you manage the capital structure, but if you're kind of agnostic to the capital structure, what would you -- what would the strategic goals of the company be? Either to go out and add more assets? Or are there parts of the business that could be better owned by somebody else? Or do you want to be part of a larger entity? I mean what's the sort of long-term strategy here?

Cheryl Maguire

executive
#33

Yes. So I mean we agree. I think we're pretty small to be a public company and so we would like to grow the platform. And I think that makes a lot of sense in a couple of different areas. We would be looking for acquisitions that are kind of down the fairway in terms of providing synergies, whether would they be on the ag side but also on the industrial side. We really like the industrial business and there's opportunities that exist on that side of the business as well. And so we definitely would like to be the consolidator. There are some smaller companies out there that are in a comparable size to us. And so we think that there is a path to progress on growing the company. And we actually also think that a transaction like that would also act as a catalyst to fix the capital structure at the same time, potentially. So there's definitely some things that we would like to do to grow the company.

Vincent Andrews

analyst
#34

And would you characterize the -- I mean we're starting to see some transactions take place post -- COVID obviously shut things down for a long time. But in the last few months, we've seen a few different types of transactions take place, not so much on the ag side of equation but more on the sort of general chemical industrial side of the equation. Are you seeing dialogue pick back up? Are bid-ask spreads still very wide? Or how would you characterize the situation?

Cheryl Maguire

executive
#35

Yes. I mean I think that the pandemic certainly did shut things down for a while, but I would agree with you. We've definitely seen things start to pick back up in the conversations that we had. And so we've -- I think things are starting to look up.

Vincent Andrews

analyst
#36

Okay. All right. Let me see if we have questions from the so-called studio audience. I don't. Is there anything that we didn't talk about that you want to make sure that those listening are aware of?

Cheryl Maguire

executive
#37

I guess the only thing I would point out is LSB has been on a path to continuous improvement and really trying to improve the reliability of the plants and become a best-in-class chemical operator. And I think we've -- or hopefully, that has been noticed and people are seeing the improvements that we've been making and we'll continue to do so. And I think we have some good things happening and some good optimism heading into next year with respect to pricing as well as our focus on the things that we can't control on a day-to-day here at LSB. So we look forward to telling you more about our improvement in the future.

Vincent Andrews

analyst
#38

Okay. Excellent. I think with that, we'll end the session here. Cheryl, thank you very much for your time today. We appreciate it.

Cheryl Maguire

executive
#39

Thank you so much, Vincent. Have a good day.

Vincent Andrews

analyst
#40

You, too, now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete LSB Industries, Inc. transcript — plus 248,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to LSB Industries, Inc. earnings transcripts and 248,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.